Jean-Claude Maher takes helm at MeDirect Group

Jean-Claude Maher is no stranger to Malta. The newly appointed Group CEO at MeDirect has been a regular visitor over the past two years, having joined the pan-European digital bank as Group Chief Operating Officer in 2023.

“Joining MeDirect was a big change for me,” explains Maher, who previously spent nearly 30 years in more traditional banking environments. “I was looking for a vibrant, dynamic organisation which is focused on leveraging new technology to meet customer expectations, and I certainly found that at MeDirect. Joining MeDirect also meant an introduction to Malta, where the bank has its origins and where most of our tech development takes place. It’s been a hectic but very enjoyable period, and I am now looking forward to relocating to Malta on a permanent basis in the coming weeks.”

The past two years have seen significant growth for the MeDirect Group. The group now serves more than 155,000 customers who hold over €5.8 billion in deposits and investments. During this time, MeDirect has continued to enhance its platform, providing customers across its three core markets—Malta, Belgium, and the Netherlands—with a digital banking and mobile app ecosystem that delivers seamless access to daily banking services and the ability to trade thousands of financial instruments. The bank in Malta has also launched a separate platform to serve the specific needs of its growing portfolio of corporate clients.

“Scaling a fintech is no easy task. You need great teams which understand changing customer behaviours and have the technical expertise to create and build a great experience that works across multiple jurisdictions. I am proud of what we have achieved, thanks in no small part to the vision and determination of Arnaud Denis, our previous CEO. During my time as COO, my focus has been on developing robust but agile processes that have facilitated this growth,” says Maher. “We now have a platform that is scalable and adaptable to local market conditions as well as to the needs of customers in both the retail and corporate markets. This puts us in a great position to drive further expansion and disrupt the financial services industry in Malta and across Europe. It’s this potential that excites me as I take on this new role.”

The new leadership at MeDirect is not expected to bring any immediate, significant changes, given that Maher’s appointment as Group CEO is still pending regulatory approval. That said, Maher is firmly focused on the future and how MeDirect can be a key player in a fast-changing world.

“The challenges facing all of us are many. In the banking sector, we may have returned to a more normal interest rate environment, but like all sectors, we face the challenge of increasing economic and political volatility. There is also the never-ending advance of technology, with AI playing a greater role across all functions of the bank. The fact that MeDirect has been built with an agile, innovative culture at its core means we are much more able to adapt and change quickly, delivering what retail and corporate customers expect within very short timeframes. Digital banking needs to continue to become more personalised and intuitive so customers can plan and manage their financial journeys with confidence. There’s nothing easy about any of this, but I have every confidence that MeDirect is brilliantly positioned to adapt and thrive,” concludes Maher.

Epic Investment Partners Views: The Week Ahead

This week’s key economic data, the BoE’s rate decision (Thu) and the US employment report (Fri) will keep markets on their toes. This morning’s China Caixin manufacturing PMI came in below expectations, however, remained in expansion, just, at 50.1.  

Also today we have a host of PMI prints, and US ISM manufacturing data, and we will hear from the Fed’s Bostic (and again on Tue) and Musalem. US Factory orders and durable goods are due on Tuesday, we also have the Alphabet quarterly earnings report, and the Fed’s Daly speaks on an economic forecast panel. China Caixin services PMI hits the screens on Wednesday and later we have eurozone services, PMI and PPI prints as well as US trade data. Chatter from the Fed’s Goolsbee and Barkin, and the ECB’s Lane may also be of interest. Eurozone retail sales, Germany factory orders and US initial jobless claims follow on Thursday. Amazon earnings will garner market focus, as will comments from the Fed’s Waller. The all-important US employment report and Uni. of Michigan consumer sentiment readings close the week.  

Asset classes will likely remain volatile this week given Trump’s weekend announcement of punitive tariffs against Canada, Mexico, China, and threats against the EU. The news, this morning, triggered a major market sell-off, with the dollar surging 1% and stocks slumping across global markets. The protectionist measures, set to take effect February 4 barring last-minute deals, have already prompted retaliatory tariff announcements from Canada and Mexico, while China vowed “corresponding countermeasures” and plans to file a WTO complaint. 

Last week kicked-off with DeepSeek news catching markets off guard, later we had further tariff noise from the US. The Fed held rates, as expected, the hawkish hold was followed by a marginally dovish Powell. Next the ECB cut rates by 25bps, Lagarde reiterated data dependence, and gave no future guidance on rates. US GDP missed expectations for 2.6%qoq Q4’24 expansion, coming in at 2.3% (down from 3.1%). The Fed’s favoured inflation reading, PCE was bang in-line with market expectations: headline up 2.6%yoy; core rose 2.8%yoy. Interestingly, the three-month annualised core rate fell to 2.2% – its lowest since July – signalling improving inflation trends that could support continued Fed rate cuts while maintaining economic growth. 


Epic Investment Partner’s Key risks & Disclaimers:

EPIC Global Equity Fund (the “Fund”) is a sub-fund of EPIC Funds p.l.c. (the “Company”), which is an open-ended umbrella fund authorised in Ireland as a UCITS fund and regulated by the Central Bank of Ireland. This marketing material has been approved in the UK by EPIC Markets (UK) LLP, trading as EPIC Investment Partners, which is a limited liability partnership incorporated and registered in England and Wales under partnership OC306260 with its registered office at Audrey House, 16-20 Ely Place, London EC1N 6SN. EPIC Markets (UK) LLP is regulated by the Financial Conduct Authority. Distribution of this material and the offer of the Fund are specifically restricted in certain jurisdictions. In particular, but without limitation, neither this material nor shares in the Fund are available to US persons.

This document is for general information purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. It is not a personal recommendation and it should not be regarded as a solicitation or an offer to buy or sell any shares in the Fund. This document represents the views of EPIC Investment Partners at the time of writing. It should not be construed as investment advice. Any person interested in investing in the Fund should conduct their own investigation and analysis of the Fund and should consult their own professional tax, accounting or other advisers as to the risks involved in making such an investment. Full details of the Fund’s investment objectives, investment policy and risks are set out in the Fund’s Prospectus and Supplement which, together with the Key Information Document (“KID”), are available on request and free of charge from Maples Fund Services (Ireland) Limited, 32 Molesworth Street, Dublin 2, Ireland and, in the UK, from EPIC Markets (UK) LLP, Audrey House, 16-20 Ely Place, London EC1N 6SN. Any offering of the Fund is only made on the terms of the current Prospectus, Supplement and KID. A subscription in the Fund can only be made after the provision of the KIID and should be made solely upon the information contained in the Prospectus, Supplement and KID.

An investment in the Fund is not suitable for an investor who cannot sustain a loss on their investment. There is no guarantee of the Fund’s future performance and past performance is not a reliable indicator of future performance. The value of your investment and the income derived from it can go down as well as up, and you may not get back the money you invested. The risks associated with making an investment in the Fund are described in the Prospectus and Supplement but investors should note, in particular, the following: 1) Foreign currency denominated investments are subject to fluctuations in exchange rates that could have a positive or an adverse effect on an investor’s returns. There is also a risk that currency hedging transactions for one share class may in extreme cases adversely affect the net asset value of the other share classes within the same sub-fund since there is no legal segregation between share classes; 2) The Fund is subject to the risk of the insolvency of its counterparties; and 3) Emerging market securities are subject to greater social, political, regulatory, and currency risks than developed market securities. This may impact the liquidity and value of such securities and, consequently, the value of the Fund.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from EPIC Investment Partners. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.